TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès(Université Paris-Sud), Laurence Zitvogel(Institut Gustave Roussy), Christos Christidis(Délégation Paris 5), Isabelle Cremer(Délégation Paris 5), Sylvie Rusakiewicz(Inserm), Kristina Iribarren(Délégation Paris 5), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Xavier Mariette(Inserm), Benoı̂t L. Salomon(Centre National de la Recherche Scientifique), Connie P.M. Duong(Peter MacCallum Cancer Centre), Mark J. Smyth(Peter MacCallum Cancer Centre), Charles Honoré(Institut Gustave Roussy), Gautier Stoll(Délégation Paris 5), Takahiro Yamazaki(Inserm), Aurélie Fluckiger(Délégation Paris 5), Bertrand Routy(Centre Hospitalier de l’Université de Montréal), Olivier Mir(Institut Gustave Roussy), Guido Kroemer(Institut Universitaire de France), Anne Caignard(Inserm), Valérie Le Brun-Ly, Pierre Validire, A. Lecesne(Institut Gustave Roussy), Anne Berger(Délégation Paris 5), L. Chaigneau(Centre Hospitalier Universitaire de Besançon), Laetitia Fend(Transgene (France)), Julien Adam(Inserm)
Cited by 42
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
|Immunity|2013|4.7k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
The molecular machinery of regulated cell death
|Cell Research|2019|2.5k